Intelligent OMICS
Intelligent OMICS turns large biological data into actionable insights for drug discovery. It uses proprietary AI, including high-speed artificial neural networks, to identify overlooked biological targets and connect drives to therapeutic modalities such as new or repurposed drugs and biomarker panels. The company operates as a translational biology service provider, collaborating with pharma and biotech partners on fee-for-service projects and pursuing in-house programs, including lung cancer/KRAS initiatives. It aims to transform biological data into clinical benefits by enabling faster target discovery, validation, and translation from idea to IND.
Intelligent OMICS
Intelligent OMICS turns large biological data into actionable insights for drug discovery. It uses proprietary AI, including high-speed artificial neural networks, to identify overlooked biological targets and connect drives to therapeutic modalities such as new or repurposed drugs and biomarker panels. The company operates as a translational biology service provider, collaborating with pharma and biotech partners on fee-for-service projects and pursuing in-house programs, including lung cancer/KRAS initiatives. It aims to transform biological data into clinical benefits by enabling faster target discovery, validation, and translation from idea to IND.